MYCEPT S 360MG TAB

About

Mycophenolate sodium is an advanced immunosuppressant medication primarily indicated for the prophylaxis of organ rejection in adult patients receiving allogeneic kidney, heart, or liver transplants. It functions as a prodrug, which is rapidly converted in vivo to its active metabolite, mycophenolic acid (MPA). MPA exerts its immunosuppressive effects by selectively and reversibly inhibiting inosine monophosphate dehydrogenase (IMPDH), a key enzyme in the de novo pathway of guanosine nucleotide synthesis. This pathway is particularly critical for the proliferation and function of T and B lymphocytes, which are central to the immune response leading to graft rejection. By depleting guanosine nucleotides, MPA effectively inhibits lymphocyte proliferation and antibody formation, thereby suppressing the immune system's attack on the transplanted organ. Its selective action on lymphocytes makes it a valuable component of combination immunosuppressive regimens, often used alongside calcineurin inhibitors and corticosteroids, to enhance efficacy and minimize toxicity.

Uses

• Prevention of acute organ rejection in kidney transplant patients.
• Prevention of acute organ rejection in heart transplant patients.
• Prevention of acute organ rejection in liver transplant patients.
• Treatment of certain autoimmune diseases (off-label use).

Directions For Use

Take orally as prescribed by your doctor, usually twice daily, on an empty stomach. Swallow the tablets whole; do not crush, chew, or break them.

Benefits

• Effective in preventing acute organ transplant rejection.
• Reduces the incidence of graft loss.
• Often used as part of a combination immunosuppressive regimen.
• Generally well-tolerated compared to some other immunosuppressants.
• Helps maintain long-term graft function.
• Improves patient outcomes post-transplant.

Side Effects

• Gastrointestinal disturbances (diarrhea, nausea, vomiting)
• Leukopenia (low white blood cell count)
• Anemia
• Thrombocytopenia (low platelet count)
• Increased risk of infections (bacterial, viral, fungal)
• Increased risk of certain malignancies (lymphoma, skin cancer)
• Headache
• Hypertension
• Peripheral edema
• Insomnia
• Tremor
• Abdominal pain

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may exacerbate gastrointestinal side effects and potentially increase the risk of liver issues.
• Pregnancy - Mycophenolate is highly teratogenic and can cause severe birth defects. It is contraindicated in pregnancy, and effective contraception is mandatory for women of childbearing potential.
• Breastfeeding - Mycophenolate is excreted in breast milk and can cause serious adverse effects in nursing infants. Breastfeeding is contraindicated during treatment.
• Liver - Use with caution in patients with severe liver impairment; dose adjustments may be necessary due to altered metabolism.
• Kidney - Use with caution in patients with severe chronic kidney impairment; dose adjustments may be required, especially in non-transplant patients.
• Lung - Mycophenolate can rarely cause interstitial lung disease or pulmonary fibrosis. Monitor for new or worsening respiratory symptoms like cough or dyspnea.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.